Clinical Trials Browser

Prostatic Neoplasms × Fluorodeoxyglucose F18 × 30 days × Clear all

NCT03181867 2026-04-22

18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT03173924 2026-04-06

18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer

Phase 2 Active not recruiting

Disease, Prostatic Neoplasms